Skip to main content
Year archive

ArcticZymes Technologies — 2026 filings

All 32 regulatory filings released by ArcticZymes Technologies (AZT) in 2026, sourced directly from the official regulator.

32 Filings
2026 Period
2026 filings (32)
Filing Released Lang
ArcticZymes Technologies Strengthens Board with Appointment of Dr. Hanna Pirita Lesch, Supporting Diversification into RNA and Continued Leadership in Cell & Gene Therapy - Attachment: ArcticZymes_Boa
Board/Management Information
2026-05-28 English
ArcticZymes Technologies Strengthens Board with Appointment of Dr. Hanna Pirita Lesch, Supporting Diversification into RNA and Continued Leadership in Cell & Gene Therapy
Board/Management Information
2026-05-28 English
ArcticZymes Technologies ASA - Minutes form Annual General Meeting 2026 - Attachment: Minutes_of_AGM_AZT_2026.pdf
AGM Information
2026-05-28 Norwegian Bokmål
ArcticZymes Technologies ASA - Minutes form Annual General Meeting 2026
Report Publication Announcement
2026-05-28 English
ArcticZymes Technologies ASA - flagging av fullmakter
Declaration of Voting Results & Voting Rights Announcements
2026-05-27 Norwegian Bokmål
ArcticZymes Technologies Delivers 36% Sales Growth in Q1 2026, with Molecular Tools Rebound and Biomanufacturing Momentum - Attachment: AZT_Q1_2026_Press_release.pdf
Interim / Quarterly Report Q1 2026
2026-05-07 Norwegian
ArcticZymes Technologies Delivers 36% Sales Growth in Q1 2026, with Molecular Tools Rebound and Biomanufacturing Momentum - Attachment: AZT_Q1_2026_Presentation.pdf
Call Transcript
2026-05-07 Norwegian
ArcticZymes Technologies Delivers 36% Sales Growth in Q1 2026, with Molecular Tools Rebound and Biomanufacturing Momentum - Attachment: AZT_Q1_2026_Report.pdf
Interim / Quarterly Report Q1 2026
2026-05-07 English
ArcticZymes Technologies Delivers 36% Sales Growth in Q1 2026, with Molecular Tools Rebound and Biomanufacturing Momentum
Interim / Quarterly Report Q1 2026
2026-05-07 Norwegian
ArcticZymes Technologies ASA: Notice of Annual General Meeting - Attachment: Notice_of_AGM_2026.pdf
AGM Information
2026-05-06 Norwegian
ArcticZymes Technologies ASA: Notice of Annual General Meeting
AGM Information
2026-05-06 Norwegian
ArcticZymes Technologies ASA: Invitation to presentation of Q1 2026
Investor Presentation
2026-05-04 English
ArcticZymes Technologies ASA - Annual Report and ESG report for 2025 - Attachment: AZT_2025_ESG_report.pdf
Environmental & Social Information
2026-04-30 Norwegian
ArcticZymes Technologies ASA - Annual Report and ESG report for 2025 - Attachment: ArcticZymes_Technologies_ASA_2025_12_31_EN.zip
Annual Report FY 2025
2026-04-30 English
ArcticZymes Technologies ASA - Annual Report and ESG report for 2025 - Attachment: AZT_2025_Annual_report.pdf
Annual Report FY 2025
2026-04-30 Norwegian
ArcticZymes Technologies ASA - Annual Report and ESG report for 2025
Report Publication Announcement
2026-04-30 English
ArcticZymes Technologies strengthens IP platform with new patent grant supporting expansion into RNA therapeutics manufacturing - Attachment: ET_N1_IP_Announcement.pdf
Regulatory Filings
2026-04-30 English
ArcticZymes Technologies strengthens IP platform with new patent grant supporting expansion into RNA therapeutics manufacturing
Regulatory Filings
2026-04-30 English
ArcticZymes Expands acib Collaboration and Joins CAARE Consortium to Advance Viral Vector Bioprocessing - Attachment: ArcticZymes_Expands_acib_Collaboration_and_Joins_CAARE.pdf
Regulatory Filings
2026-04-28 English
ArcticZymes Expands acib Collaboration and Joins CAARE Consortium to Advance Viral Vector Bioprocessing
Regulatory Filings
2026-04-28 English
ArcticZymes Technologies ASA - flagging
Major Shareholding Notification
2026-04-14 Norwegian
ArcticZymes Technologies ASA - Capital Markets Day 2026. Scaling a High-Performance Enzyme Platform for Compounding Growth - Attachment: AZT_CMD_2026_Presentation.pdf
Investor Presentation
2026-03-06 English
ArcticZymes Technologies ASA - Capital Markets Day 2026. Scaling a High-Performance Enzyme Platform for Compounding Growth - Attachment: AZT_CMD_2026_Press_release.pdf
Investor Presentation
2026-03-06 English
ArcticZymes Technologies ASA - Capital Markets Day 2026. Scaling a High-Performance Enzyme Platform for Compounding Growth
Report Publication Announcement
2026-03-06 English
ArcticZymes Technologies ASA: Reminder - Capital Markets Day, 6 March 2026
Regulatory Filings
2026-03-03 English
ArcticZymes Releases New White Paper Quantifying the Impact of Optimized Nuclease Strategy on Viral Vector Manufacturing Economics - Attachment: Economics_of_SAN_26022026.pdf
Regulatory Filings
2026-02-26 English
ArcticZymes Releases New White Paper Quantifying the Impact of Optimized Nuclease Strategy on Viral Vector Manufacturing Economics
Report Publication Announcement
2026-02-26 English
ArcticZymes Technologies Reports Strong Q4 and FY 2025. Accelerating Sales Growth and Improved Profitability - Attachment: AZT_Q4_2025_Press_release.pdf
Earnings Release FY 2025
2026-02-12 English
ArcticZymes Technologies Reports Strong Q4 and FY 2025. Accelerating Sales Growth and Improved Profitability - Attachment: AZT_Q4_2025_Presentation.pdf
Earnings Release Q4 2025
2026-02-12 English
ArcticZymes Technologies Reports Strong Q4 and FY 2025. Accelerating Sales Growth and Improved Profitability - Attachment: AZT_Q4_2025_Report.pdf
Interim / Quarterly Report Q4 2025
2026-02-12 English
ArcticZymes Technologies Reports Strong Q4 and FY 2025. Accelerating Sales Growth and Improved Profitability
Earnings Release Q4 2025
2026-02-12 English
ArcticZymes Technologies ASA: Invitation to presentation of Q4 and FY 2025 results
Report Publication Announcement
2026-02-05 English